These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21242236)

  • 1. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments.
    Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Wakefield R; Karim Z; Quinn M; Hensor E; Conaghan PG; Emery P
    Ann Rheum Dis; 2011 May; 70(5):792-8. PubMed ID: 21242236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
    Geng Y; Han J; Deng X; Zhang Z
    Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis.
    Sakellariou G; Scirè CA; Verstappen SM; Montecucco C; Caporali R
    Ann Rheum Dis; 2013 Feb; 72(2):245-9. PubMed ID: 23060009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
    Terslev L; Brahe CH; Østergaard M; Fana V; Ammitzbøll-Danielsen M; Møller T; Krabbe S; Hetland ML; Døhn UM
    Arthritis Res Ther; 2021 Feb; 23(1):48. PubMed ID: 33522948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography.
    Janta I; Naredo E; Martínez-Estupiñán L; Nieto JC; De la Torre I; Valor L; Estopiñán L; Bello N; Hinojosa M; González CM; López-Longo J; Monteagudo I; Montoro M; Carreño L
    Rheumatology (Oxford); 2013 Dec; 52(12):2243-50. PubMed ID: 24046468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musculoskeletal ultrasound as a biomarker of remission - results from a one-year prospective study in patients with rheumatoid arthritis.
    Sapundzhieva T; Karalilova R; Batalov A
    Med Ultrason; 2018 Dec; 20(4):453-460. PubMed ID: 30534652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of composite indices with global synovitis score on ultrasound for detecting remission.
    Olmez MO; Gunal EK; Ureyen SB; Keskin H; Ozturk AB; Yeter G; Cobanoglu E; Aydin SZ
    Clin Rheumatol; 2018 Apr; 37(4):1111-1114. PubMed ID: 29181728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state.
    Gandjbakhch F; Conaghan PG; Ejbjerg B; Haavardsholm EA; Foltz V; Brown AK; Møller Døhn U; Lassere M; Freeston J; Bøyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Hørslev-Petersen K; Kvien TK; McQueen F; Ostergaard M
    J Rheumatol; 2011 Sep; 38(9):2039-44. PubMed ID: 21885514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
    Ventura-Ríos L; Sánchez Bringas G; Hernández-Díaz C; Cruz-Arenas E; Burgos-Vargas R
    Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy.
    Dale J; Purves D; McConnachie A; McInnes I; Porter D
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):19-26. PubMed ID: 24376248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
    Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
    Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission.
    Ben Abdelghani K; Miladi S; Makhlouf Y; Fazaa A; Sallemi M; Souebni L; Ouenniche K; Kassab S; Chekili S; Ben Salem K; Zakraoui L; Laatar A
    Sultan Qaboos Univ Med J; 2022 Nov; 22(4):554-560. PubMed ID: 36407714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study.
    Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P
    Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
    Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
    Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Celis R; Ruiz-Esquide V; Castellanos-Moreira R; Ponce A; Gómez-Puerta JA; Sanmartí R; Cañete JD
    Clin Rheumatol; 2021 Jul; 40(7):2665-2672. PubMed ID: 33506371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does patients' opinion of remission in rheumatoid arthritis overlap ultrasound "true" remission? - a pilot study.
    Vlad V; Berghea F; Iorgoveanu V; Popescu M; Predeteanu D; Ionescu R
    Med Ultrason; 2018 Aug; 20(3):328-334. PubMed ID: 30167586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.